Author:
Lindgren Peter,Kahan Thomas,Poulter Neil,Buxton Martin,Svarvar Patrick,Dahlöf Björn,Jönsson Bengt,
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference20 articles.
1. Sever, P.S., Dahlof, B., Poulter, N.R., et al.: Rationale, design, methods and baseline demography of participants of the Anglo—Scandinavian cardiac outcomes trial. ASCOT investigators. J. Hypertens. 19, 1139–1147 (2001)
2. Sever, P.S., Dahlof, B., Poulter, N.R., et al.: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo—Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361, 1149–1158 (2003)
3. Dahlof, B., Sever, P.S., Poulter, N.R., et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo—Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366, 895–906 (2005)
4. Lindgren, P., Buxton, M., Kahan, T., et al.: Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo—Scandinavian cardiac outcomes trial–lipid-lowering arm (ASCOT-LLA). Eur. J. Cardiovasc. Prev. Rehabil. 12, 29–36 (2005)
5. Läkemedelsförmånsnämnden, Läkemedelsförmånsnämnden allmänna råd om ekonomiska utvärderingar. Stockholm (2003)
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献